Artal Group’s Atara Biotherapeutics ATRA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000,000	Closed	-$7.79M	–	134
2022 Q2	$7.79M	Hold	1,000,000	–	–	0.42%	42
2022 Q1	$9.29M	Sell	1,000,000 -500,000	-33%	-$4.65M	0.39%	50
2021 Q4	$23.6M	Hold	1,500,000	–	–	0.64%	37
2021 Q3	$26.9M	Hold	1,500,000	–	–	0.6%	33
2021 Q2	$23.3M	Sell	1,500,000 -500,000	-25%	-$7.78M	0.47%	40
2021 Q1	$28.7M	Sell	2,000,000 -800,000	-29%	-$11.5M	0.51%	37
2020 Q4	$55M	Buy	2,800,000 +550,000	+24%	+$10.8M	1.18%	22
2020 Q3	$29.2M	Sell	2,250,000 -250,000	-10%	-$3.24M	0.71%	26
2020 Q2	$36.4M	Hold	2,500,000	–	–	1.02%	20
2020 Q1	$21.3M	Buy	2,500,000 +750,000	+43%	+$6.38M	0.9%	24
2019 Q4	$28.8M	Buy	1,750,000 +250,000	+17%	+$4.12M	1.11%	18
2019 Q3	$21.2M	Buy	1,500,000 +350,000	+30%	+$4.94M	0.85%	17
2019 Q2	$23.1M	Hold	1,150,000	–	–	0.94%	23
2019 Q1	$45.7M	Buy	1,150,000 +150,000	+15%	+$5.96M	1.87%	11
2018 Q4	$34.7M	Hold	1,000,000	–	–	1.29%	12
2018 Q3	$41.4M	Hold	1,000,000	–	–	1.08%	10
2018 Q2	$36.8M	Sell	1,000,000 -250,000	-20%	-$9.19M	0.78%	10
2018 Q1	$48.8M	Buy	1,250,000 +250,000	+25%	+$9.75M	0.61%	7
2017 Q4	$18.1M	Buy	1,000,000 +400,000	+67%	+$7.24M	0.27%	13
2017 Q3	$9.93M	Buy	600,000 +100,000	+20%	+$1.66M	0.17%	20
2017 Q2	$7M	Hold	500,000	–	–	0.12%	26
2017 Q1	$10.3M	Hold	500,000	–	–	0.23%	22
2016 Q4	$7.1M	Buy	500,000 +275,000	+122%	+$3.91M	0.16%	24
2016 Q3	$4.81M	Buy	+225,000	New	+$4.81M	0.1%	37